sacituzumab govitecan April 12, 2017 sacituzumab govitecan Trade Name Orphan Indication Small cell lung cancer USA Market Approval USA USA Designation Date 2013-11-27 00:00:00 Sponsor Immunomedics, Inc.;300 The American Road;Morris Plains, New Jersey, 07950